Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Texting for Relapse Prevention Among People Diagnosed With Schizophrenia or SAD

NCT02819349 is registered in ClinicalTrials.gov with Center for Innovative Public Health Research as lead sponsor.

NCT NCT02819349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02819349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Texting for Relapse Prevention Among People Diagnosed With Schizophrenia or SAD
Lead sponsor
Center for Innovative Public Health Research
Phase
Not applicable
Overall status
Completed
Start date
March 12, 2018
Completion date
April 9, 2019
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia